<DOC>
	<DOCNO>NCT00867867</DOCNO>
	<brief_summary>Iron fortification food usually consider cost-effective approach prevent iron deficiency . However , iron difficult mineral add food . When add water-soluble , highly bioavailable compound ferrous sulfate , soluble iron rapidly catalyze fat oxidation result rancid product . In addition , water-soluble iron compound cause unacceptable color reaction storage food preparation . Thus , food manufacturer often oblige use water-insoluble iron compound fortify food fortification compound elemental Fe powder ferric pyrophosphate widely use fortify cereal flour infant cereal . However , compound never dissolve completely gastric juice usually far less well absorbed ferrous sulfate ( Hurrell 1997 ) . Ferrous fumarate hand , although almost insoluble water , readily dissolve gastric juice show equivalent absorption ferrous sulfate healthy , Western adult ( Hurrell et al . 1989 , 2000 ) . Because non-water soluble , cause relatively sensory problem fortify food therefore interest food fortificant . Iron absorption ferrous fumarate demonstrate significantly high ferric pyrophosphate European infant ( Davidsson et al . 2000 ) compound currently use fortify blend cereal flour food aid program commercial infant cereal Europe . However , base recent study Bangladeshi child , concern due low gastric acid output , young child develop country may able absorb ferrous fumarate well Western adult ( Davidsson et al . 2001a , Sarker et al . 2001 , 2003 ) . Clearly , need evaluate efficacy water insoluble iron compound prevent development iron deficiency/iron deficiency anemia infant young child live develop country . The aim study evaluate efficacy ferrous fumarate ferric pyrophosphate , compare ferrous sulfate , food fortificants prevent development anemia/IDA Bangladeshi infants young child ( part I ) . A potential cause low gastric acid secretion Bangladesh many develop country Helicobacter pylorus infection . Although H. pylori-infection appear influence absorption ferrous fumarate child , impact chronic H. pylorus infection adult could expect pronounced due long time effect gastric mucosa , result reduce gastric acid output . The aim study therefore , assess iron absorption gastric acid output adult woman child-bearing age H. pylorus infection ( part II ) . Two hundred forty non-anemic Children ( Hb &gt; 105 g/L ) randomize three study group ; ferrous fumarate , ferric pyrophosphate ferrous sulfate ( n=80 per group ) wheat flour- cow milk-based infant formula feed 9 month . Hemoglobin , serum ferritin , transferin receptor analyze baseline 4.5 9 month intervention . Prevalence anemia iron deficiency intervention among three group compare ( part I ) . We furthermore propose complementary study determine relative absorption ferrous fumarate ( relative ferrous sulfate ) H. pylorus infect non-infected adult Bangladeshi woman ( 15 ) 20-40 year age IDA use stable isotope technique base incorporation iron stable isotope erythrocytes 14 day administration . Assessment gastric acid output also perform . Iron stature absorption , assessment gastric acid output compare therapy H. pylorus infect woman ( part II ) . The result study expected implication prevention treatment iron deficiency anemia develop country</brief_summary>
	<brief_title>Ferrous Fumarate Ferric Pyrophosphate Food Fortificants Developing Countries</brief_title>
	<detailed_description>The efficacy study test ability ferrous fumarate ferric pyrophosphate prevent anemia/IDA non-anemic Bangladeshi infants/young child comparison ferrous sulfate 9 month feed trial . Hemoglobin indicator Fe status ( ferritin circulate transferrin receptor ) acute phase reactant ( C-reactive protein ) monitor baseline 4.5 9 month intervention . Subjects Non-anemic infant young child ( 6-24 month ; n=240 ) ( Hb &gt; 105g/L ) recruit study population Nandipara , peri-urban community near Dhaka city . All child randomize one three study group ; ferrous fumarate , ferric pyrophosphate ferrous sulfate ( n=80 per group ) , stratify base H. pylori infection ( base H. pylori stool antigen test , positive negative ) base line . All infants/young child retested H. pylorus infection end study . All parent guardian fully inform aim procedure study inform consent obtain least one parent/guardian per child . Exclusion criterion Exclusion criterion include child anemia ( Hb &lt; 105 g/L ) , systemic infection apparent inflammatory process weight age &lt; 70 % NCHS median . The child exclusion criterion appropriately treat need , referred appropriate health center treatment . Sample size : The sample size base expect anemia prevalence intervention , i.e. , child anemia 9 month intake fortify infant cereal . We assume prevalence anemia 10 % infant consume cereal fortify ferrous sulfate , 30 % infant consume cereal fortify ferrous fumarate 50 % anemia infant consume cereal fortify ferric pyrophosphate . To detect difference 20 % point ( ( P1 - P2 ) ; sulfate versus fumarate sulfate versus pyrophosphate ) 95 % confidence power=0.80 , sample size calculate 62 infants/young child per group . Assuming drop rate 25 % , recruit 80 infants/young child per group i.e . 240 non-anemic infants/young child . We assume high prevalence anemia ( 70-80 % ) study population therefore need screen approximately 1000-1200 child . Fortified food Each serve consist 25 g infant cereal base wheat rice flour cow milk ( produce especially study ; 9.3 mg Fe ferrous fumarate , ferric pyrophosphate ferrous sulfate/25 g dry cereal added manufacture . Ascorbic acid add manufacture molar ratio 3:1 relative add Fe . Fortified infant cereal administer health worker , one serve per day , 6 day per week , close supervision study physician/investigators . Intake monitor weekly , need , feed 7 day per week compensate day child sick absent . The fortified food provide Recommended Nutrient Intake iron infant 7-12 month accord WHO/FAO 2002 ( press ; please see PAHO/FNP/USAID consultation 2001 ) per serving , i.e. , 9.3 mg Fe . Fortified infant cereal feed per day , 6 day per week , 9 month . Dietary information simplify food frequency questionnaire ( SFFQ ) , validate currently use Bangladesh Integrated Nutrition Project ( BINP ) , also obtain twice month . Anthropometrical measurement e.g . weight , height , mid upper arm circumference ( MUAC ) measure baseline , 4.5 month 9 month intervention . All parent guardian fully inform aim procedure study inform consent obtain least one parent/guardian per child . All anemic infants/young child ( diagnose screening study ) treat medicinal Fe accord standard treatment practice ICDDR.B ; ( ferrous sulfate drop ; ( 2 mg Fe/kg BW/d ) 2 month . Infants/young child anemia 4.5 9 month ( efficacy study ) treat medicinal Fe ( ferrous sulfate drop ; ( 2 mg Fe/kg BW/d ) 2 month exclude study . Medicinal Fe administer health worker . Hookworm infection prevalent community child participate study screen hookworm infection time blood sample . Infected child treat Albendazole 400 mg single dose two time ( 2 week apart ) exclude intervention study . Blood analysis Venous blood sample draw ( 2 ml EDTA treat tube ) screen study identify non-anemic infants/young child baseline 4.5 9 month intervention . Hb analyze use cyanomethemoglobin method ( Sigma kit , Sigma , St Louis , MO ) . Plasma ferritin plasma circulate transferrin receptor measure ELISA technique use commercial kit initial screen study ( Ramco , Houston , TX ) . Samples draw baseline 4.5 9 month intervention analyze KUMC plasma ferritin plasma circulate transferrin receptor ELISA assay base monoclonal antibody ( Flowers et al . 1986 ) /dual monoclonal antibody ( Flowers et al . 1989 ) . Plasma sample also analyze C-reactive protein ( CRP ) KUMC . CRP monitor acute phase reactant . Dr. Cook Ms . Flowers currently develop monoclonal ELISA technique CRP , use study . Commercial quality control material ( DiaMed , Cressier sur Morat , Switzerland , Sigma Ramco ) analyze together series sample analyze Hb ferritin . Food analysis Infant cereal analyze Fe calcium ( Ca ) electrothermal/flame atomic absorption spectroscopy ( SpectrAA 400 , Varian , Mulgrave , Australia ) mineralization microwave digestion ( MLS 1200 ) use HNO3/H2O2 mixture , use standard addition technique minimize matrix effect . The phytic acid content determine HPLC technique ( Sandberg &amp; Ahderinne 1986 , Sandberg et al . 1989 Fecal sample ; screen H. pylori infection hookworm infection Stool specimen collect tested presence H. pylorus antigen ( HpSA ) newly develop enzyme immunoassay ( EIA ) . A polyclonal commercial kit ( H. pylori antigen EIA ; Cat # 740096 , Novitech , Freiburg , Germany ) use . The HpSA test demonstrate sensitive ( &gt; 80 % ) specific ( &gt; 95 % ) detection H.pylori infection ( Braden et al . 2000 , Vakil et al . 2000 , Sarker et al . personal communication 2003 ) . Stool sample also screen presence parasite egg , use standard microscopic technique . Statistics ANOVA use compare variable within study group well 3 study group . Results significant F ratio ( p &lt; 0.05 ) analyze Student 's t-test use multiple comparison procedure . Different outcome variable , i.e. , Hb , ferritin , TfR concentration intervention group compare pair t-test . Data skew distribution normalize log transformation statistical analysis . Chi-squared test use evaluate binary variable different time point study . Odds Ratios confidence interval calculate . Multivariate analysis ( logistic regression multiple regression ) also perform adjust confounders , e.g . age , nutritional status .</detailed_description>
	<mesh_term>Helicobacter Infections</mesh_term>
	<mesh_term>Iron</mesh_term>
	<mesh_term>Ferrous fumarate</mesh_term>
	<criteria>Children 924 month Nonanaemic child ( haemoglobin 10.5g/L ) Exclusion criterion include : Children anemia ( Hb &lt; 105 g/L ) , systemic infection apparent inflammatory process weight age &lt; 70 % NCHS median . The child exclusion criterion appropriately treat need , referred appropriate health center treatment .</criteria>
	<gender>All</gender>
	<minimum_age>9 Months</minimum_age>
	<maximum_age>24 Months</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>Iron deficiency anemia</keyword>
	<keyword>Helicobacter pylorus</keyword>
	<keyword>Iron absorption</keyword>
	<keyword>Iron fortification</keyword>
	<keyword>ferrous sulphate</keyword>
	<keyword>ferrous fumarate</keyword>
</DOC>